Filter News
Area of Research
- (-) Computational Biology (2)
- (-) Isotope Development and Production (1)
- (-) National Security (18)
- (-) Neutron Science (37)
- Advanced Manufacturing (6)
- Biological Systems (1)
- Biology and Environment (24)
- Clean Energy (43)
- Computational Engineering (1)
- Computer Science (1)
- Electricity and Smart Grid (1)
- Fuel Cycle Science and Technology (1)
- Functional Materials for Energy (1)
- Fusion and Fission (46)
- Fusion Energy (16)
- Isotopes (10)
- Materials (94)
- Materials Characterization (1)
- Materials for Computing (15)
- Materials Under Extremes (1)
- Nuclear Science and Technology (40)
- Nuclear Systems Modeling, Simulation and Validation (2)
- Sensors and Controls (1)
- Supercomputing (41)
- Transportation Systems (1)
News Topics
- (-) Advanced Reactors (2)
- (-) Biomedical (14)
- (-) Fusion (2)
- (-) Materials Science (25)
- (-) Nuclear Energy (8)
- (-) Security (12)
- 3-D Printing/Advanced Manufacturing (8)
- Artificial Intelligence (18)
- Big Data (8)
- Bioenergy (9)
- Biology (10)
- Biotechnology (2)
- Buildings (1)
- Chemical Sciences (4)
- Clean Water (2)
- Climate Change (5)
- Composites (1)
- Computer Science (31)
- Coronavirus (10)
- Cybersecurity (19)
- Decarbonization (4)
- Energy Storage (8)
- Environment (13)
- Exascale Computing (1)
- Fossil Energy (1)
- Frontier (2)
- Grid (6)
- High-Performance Computing (7)
- Irradiation (1)
- Machine Learning (15)
- Materials (16)
- Mathematics (1)
- Microscopy (3)
- Nanotechnology (11)
- National Security (34)
- Neutron Science (99)
- Partnerships (4)
- Physics (10)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (8)
- Simulation (1)
- Space Exploration (4)
- Summit (8)
- Sustainable Energy (4)
- Transportation (7)
Media Contacts
When the COVID-19 pandemic stunned the world in 2020, researchers at ORNL wondered how they could extend their support and help
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
It’s a simple premise: To truly improve the health, safety, and security of human beings, you must first understand where those individuals are.
A team of researchers has developed a novel, machine learning–based technique to explore and identify relationships among medical concepts using electronic health record data across multiple healthcare providers.
University of Pennsylvania researchers called on computational systems biology expertise at Oak Ridge National Laboratory to analyze large datasets of single-cell RNA sequencing from skin samples afflicted with atopic dermatitis.
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
A team led by the U.S. Department of Energy’s Oak Ridge National Laboratory demonstrated the viability of a “quantum entanglement witness” capable of proving the presence of entanglement between magnetic particles, or spins, in a quantum material.
ASM International recently elected three researchers from ORNL as 2021 fellows. Selected were Beth Armstrong and Govindarajan Muralidharan, both from ORNL’s Material Sciences and Technology Division, and Andrew Payzant from the Neutron Scattering Division.
Scientists at ORNL and the University of Tennessee, Knoxville, have found a way to simultaneously increase the strength and ductility of an alloy by introducing tiny precipitates into its matrix and tuning their size and spacing.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.